Evaluate the efficacy of Vrushadya Ghrut in Psoriasis

Randomised controlled study to evaluate the efficacy of Vrushadya Ghrut in comparison with Acitretin in Kitibha Kushta with special reference to Psoriasis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043730

Enrollment

Registered

2022-07-05

Start date

Unknown

Completion date

Unknown

Last updated

2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with clinical features of Kitibha kushta having sings and symptoms namely of Shyavam (Greyish Discoloration), Kinakharsparsha (Rough like a scar), Parusha(Roughness),Kandu (itching sensation ). 2) Participant must have active plaque psoriasis covering at least 9 % body surface area and a PASI score of at least 12 at screening and at randomization. 3) Patients irrespective of gender will be included and who are willing to take medicine. 4) Age group within 18-60 years.

Exclusion criteria

Exclusion criteria: 1) Participant has pustular, erythrodermic and/or guttate forms of psoriasis. 2) Participant has had a clinically significant flare of psoriasis during the 12 weeks prior to studyentry. 3) Known case of immunocomprosied patients or on immunosuppressive drugs. 4) Patients suffering from severe systemic illness. 5) Pregnant and lactating females. 6) Psoriatic arthritis.

Design outcomes

Primary

Measure	Time frame
PhotographTimepoint: DAY 0 AND DAY 90	—

Secondary

Measure	Time frame
PASI score and Subjective symptomsTimepoint: 0 - 15 - 30 - 45 - 60 - 75 - 90TH DAY	—

Countries

India

Contacts

Public ContactDr Omkar Mankar

YMT Ayurvedic Medical College and Hospital,kharghar, Navi Mumbai

vdaparnasathe@gmail.com09819216230

Outcome results